233 related articles for article (PubMed ID: 37493986)
41. Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival.
Tumedei MM; Piccinini F; Azzali I; Pirini F; Bravaccini S; De Matteis S; Agostinelli C; Castellani G; Zanoni M; Cortesi M; Vergani B; Leone BE; Righi S; Gazzola A; Casadei B; Gentilini D; Calzari L; Limarzi F; Sabattini E; Pession A; Tazzari M; Bertuzzi C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373066
[TBL] [Abstract][Full Text] [Related]
42. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
Sureda A; Zhang MJ; Dreger P; Carreras J; Fenske T; Finel H; Schouten H; Montoto S; Robinson S; Smith SM; Boumedil A; Hamadani M; Pasquini MC
Cancer; 2018 Apr; 124(8):1733-1742. PubMed ID: 29424927
[TBL] [Abstract][Full Text] [Related]
43. Baseline [
Yang Q; Luo Y; Zhang Y; Zhang W; Zhou D; Li F
Eur Radiol; 2022 Aug; 32(8):5568-5576. PubMed ID: 35316362
[TBL] [Abstract][Full Text] [Related]
44. Follicular lymphoma: evolving therapeutic strategies.
Kahl BS; Yang DT
Blood; 2016 Apr; 127(17):2055-63. PubMed ID: 26989204
[TBL] [Abstract][Full Text] [Related]
45. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
[TBL] [Abstract][Full Text] [Related]
46. Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.
Casulo C; Day B; Dawson KL; Zhou X; Flowers CR; Farber CM; Hainsworth JD; Cerhan JR; Link BK; Zelenetz AD; Friedberg JW
Ann Oncol; 2015 Nov; 26(11):2311-7. PubMed ID: 26362568
[TBL] [Abstract][Full Text] [Related]
47. Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
Correia C; Maurer MJ; McDonough SJ; Schneider PA; Ross PE; Novak AJ; Feldman AL; Cerhan JR; Slager SL; Witzig TE; Eckloff BW; Li H; Nowakowski GS; Kaufmann SH
Blood Cancer J; 2023 May; 13(1):81. PubMed ID: 37193683
[TBL] [Abstract][Full Text] [Related]
48. Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copies.
Bussot L; Chevalier S; Cristante J; Grange B; Tesson B; Deteix-Santana C; Orsini-Piocelle F; Leyronnas C; Dupire S; Gressin R; Salles G; Bachy E; Emadali A; Valmary-Degano S; Huet S; Lefebvre C; Carras S
Br J Haematol; 2021 Jul; 194(2):382-392. PubMed ID: 34155628
[TBL] [Abstract][Full Text] [Related]
49. Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.
Juskevicius D; Jucker D; Klingbiel D; Mamot C; Dirnhofer S; Tzankov A
J Hematol Oncol; 2017 Mar; 10(1):70. PubMed ID: 28302137
[TBL] [Abstract][Full Text] [Related]
50. Plasma Concentrations and Cancer-Associated Mutations in Cell-Free Circulating DNA of Treatment-Naive Follicular Lymphoma for Improved Non-Invasive Diagnosis and Prognosis.
Hatipoğlu T; Esmeray Sönmez E; Hu X; Yuan H; Danyeli AE; Şeyhanlı A; Önal-Süzek T; Zhang W; Akman B; Olgun A; Özkal S; Alacacıoğlu İ; Özcan MA; You H; Küçük C
Front Oncol; 2022; 12():870487. PubMed ID: 35795062
[TBL] [Abstract][Full Text] [Related]
51. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.
Salaverria I; Weigert O; Quintanilla-Martinez L
Blood Adv; 2023 Sep; 7(18):5258-5271. PubMed ID: 37561599
[TBL] [Abstract][Full Text] [Related]
52. Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study.
Kridel R; Chan FC; Mottok A; Boyle M; Farinha P; Tan K; Meissner B; Bashashati A; McPherson A; Roth A; Shumansky K; Yap D; Ben-Neriah S; Rosner J; Smith MA; Nielsen C; Giné E; Telenius A; Ennishi D; Mungall A; Moore R; Morin RD; Johnson NA; Sehn LH; Tousseyn T; Dogan A; Connors JM; Scott DW; Steidl C; Marra MA; Gascoyne RD; Shah SP
PLoS Med; 2016 Dec; 13(12):e1002197. PubMed ID: 27959929
[TBL] [Abstract][Full Text] [Related]
53. The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma.
Hu X; Baytak E; Li J; Akman B; Okay K; Hu G; Scuto A; Zhang W; Küçük C
Leuk Res; 2017 Mar; 54():30-38. PubMed ID: 28095352
[TBL] [Abstract][Full Text] [Related]
54. Progression of disease within 24 months of initial therapy (POD24) detected incidentally in imaging does not necessarily indicate worse outcome.
Bitansky G; Avigdor A; Vasilev E; Zlotnick M; Ribakovsky E; Benjamini O; Nagler A; Kedmi M
Leuk Lymphoma; 2020 Nov; 61(11):2645-2651. PubMed ID: 32643497
[TBL] [Abstract][Full Text] [Related]
55. Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance.
Barraclough A; England JT; Villa D; Wight J; Hapgood G; Conn J; Doo NW; Li EW; Gilbertson M; Shaw B; Bishton MJ; Saeed M; Ratnasingam S; Abeyakoon C; Chong G; Wai SH; Ku M; Lee HP; Fleming K; Tam C; Douglas G; Cheah CY; Ng ZY; Rolfe T; Mills AK; Hamad N; Cashman H; Gleeson M; Narayana M; Hawkes EA
Haematologica; 2023 Sep; 108(9):2444-2453. PubMed ID: 36815381
[TBL] [Abstract][Full Text] [Related]
56. [Clinical Significance of Detecting CD4
Liu W; Zhagn GX; Shi WZ; Dong L; Liu H; Shen XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):449-454. PubMed ID: 28446291
[TBL] [Abstract][Full Text] [Related]
57. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
González-Rincón J; Méndez M; Gómez S; García JF; Martín P; Bellas C; Pedrosa L; Rodríguez-Pinilla SM; Camacho FI; Quero C; Pérez-Callejo D; Rueda A; Llanos M; Gómez-Codina J; Piris MA; Montes-Moreno S; Bárcena C; Rodríguez-Abreu D; Menárguez J; de la Cruz-Merino L; Monsalvo S; Parejo C; Royuela A; Kwee I; Cascione L; Arribas A; Bertoni F; Mollejo M; Provencio M; Sánchez-Beato M
PLoS One; 2019; 14(2):e0212813. PubMed ID: 30802265
[TBL] [Abstract][Full Text] [Related]
58. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation.
Green MR; Kihira S; Liu CL; Nair RV; Salari R; Gentles AJ; Irish J; Stehr H; Vicente-Dueñas C; Romero-Camarero I; Sanchez-Garcia I; Plevritis SK; Arber DA; Batzoglou S; Levy R; Alizadeh AA
Proc Natl Acad Sci U S A; 2015 Mar; 112(10):E1116-25. PubMed ID: 25713363
[TBL] [Abstract][Full Text] [Related]
59. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival.
Găman AM
Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311
[TBL] [Abstract][Full Text] [Related]
60. Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma.
Burack WR; Li H; Adlowitz D; Spence JM; Rimsza LM; Shadman M; Spier CM; Kaminski MS; Leonard JP; Leblanc ML; Smith SM; Friedberg JW
Blood Adv; 2023 Sep; 7(17):5082-5090. PubMed ID: 37379264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
